General immune system pathways

General immune system pathways refer to the integrated network of signaling cascades and cellular processes that coordinate the body's defense against pathogens and maintain tissue homeostasis (wisdomlib.org). These pathways are broadly categorized into innate immunity, which provides immediate, non-specific responses via pattern-recognition receptors (PRRs) like Toll-like receptors (TLRs), and adaptive immunity, which involves highly specific responses mediated by T and B lymphocytes (researchgate.net; nih.gov). Key molecular events include cytokine signaling, antigen presentation, and the activation of effector cells such as macrophages and natural killer (NK) cells (iqvia.com; frontiersin.org). Dysregulation of these pathways is a hallmark of various diseases, including chronic inflammation, autoimmune disorders, and cancer (mdpi.com; researchgate.net). Therapeutic strategies often involve immunomodulation, using drugs like corticosteroids or biologics to either suppress overactive responses in autoimmunity or stimulate immune activity against tumors (nih.gov). However, modulating these systemic pathways carries significant risks, such as opportunistic infections or cytokine release syndrome, due to the potential for exaggerated pharmacological effects (nih.gov). Biomarkers like C-reactive protein and various interleukins are commonly used to monitor the activity and health of these pathways in clinical settings (superpower.com).

Other names

Immune systemImmune signaling pathwaysImmunological pathwaysImmune response pathways

Drugs targeting these pathways act through diverse mechanisms such as inhibiting cytokine signaling, depleting specific immune cell populations, or blocking immune checkpoints to enhance or suppress the host immune response.